16 %Growth in revenue inspite of sectoral downturn
83.7 %Growth in Profit
19.3 %EBITDA Margin for year 2016 - 17
86 %Revenue from branded products
UPL’s wide array of crop protection products offers protection against most pest infestation sources. Over the years, we have extended beyond agrochemicals and diversified our product portfolio to seeds, seed treatment solutions, post-harvest solutions and industrial chemicals, among others. Validating our identity as a one-stop solution provider.
Over the past four decades, we created a strong presence across our sectoral value chain – R&D, registration, manufacturing, packaging and marketing. The result is that we have emerged as one of the most holistic generic agrochemical companies in the world.
UPL has established its footprint in more than 130+ countries across six continents with a visible presence in key agro-based economies like India and Brazil. This ‘glocal’ approach has de-risked us from being excessively dependent on growth coming out of a single country.
Higher Growth Geographies
Robust Innovation Pipeline
Global Talent Pool
We have invested extensively in R&D activities. We launched 57 products in the last 2 years, emphasizing strategic effectiveness. A relentless focus on innovation helped us differentiate the application of existing products.
Led by industry stalwarts, the leadership of our senior management has earned us the certification of being a 'Great Place To Work' from global institutions.
We registered products in 116 countries including the fast-growing agro markets of Brazil, India, Mexico, China, Australia, the US, Argentina, France and South Africa, among others. As a means to this end, we conducted intensive research-led and country-specific studies, ensuring seamless compliance with stringent norms.
UPL prudently invested in brand-building based on the understanding that branded products command a premium over commoditised ones. The branded product accounted should be 86% for 2016-17
We moderated our net debt-equity ratio to 0.69 as on 31 mar 2017 and our net debt-EBITDA ratio is 1.51. We strengthened our interest cover to 6.09 for 2016-17.
We restricted our net working capital cycle to 88 days of turnover equivalent.
We expanded our marketing presence across 130+ countries in six continents (supported by 33 manufacturing units in 11 countries). This facilitated customer proximity and allowed an attractive cost arbitrage leverage in manufacturing bulk chemicals in India and formulations in diverse countries.
UPL strengthened its reach through a hub-and-spoke distribution model, which allowed us to manufacture most of our bulk chemicals in India and formulate specific products in plants located closer to markets. A robust network of distributors allowed us to seamlessly distribute products and circumvent logistic bottlenecks.
We integrated operations in a manner that key products like phosphorus and chloralkali, among others, served as raw materials for the synthesis of other products. A deep integration helped us achieve qualitative consistency and cost-competitiveness.